You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematopoietic Stem Cell Transplant

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HPV-unrelated Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (Palbociclib, Cetuximab)

Recruiting
  • HPV-unrelated Head and Neck Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 7, 2022

Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Duarte, Rochester, Columbus (Best Practice, Biospecimen

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Stage III Lung Cancer AJCC v8
  • Best Practice
  • +5 more
  • Duarte, California
  • +2 more
Nov 14, 2023

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, paclitaxel)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
May 12, 2022

Follicular Lymphoma, Mantle Cell Lymphoma Trial in New York (Ribavirin)

Terminated
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2021

Acute Myeloid Leukemia Trial in Suzhou (anti-FLT3 CAR-T)

Recruiting
  • Acute Myeloid Leukemia
  • anti-FLT3 CAR-T
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 29, 2021

Refractory Brain Tumors Trial (Busulfan)

Withdrawn
  • Refractory Brain Tumors
  • (no location specified)
Aug 3, 2020

Extensive Stage Small Cell Lung Cancer Trial in Shanghai (HLX10, carboplatin and etoposide, )

Active, not recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Shanghai, China
  • +5 more
Sep 28, 2022

COVID-19 Trial (Recombinant two-component COVID-19 vaccine (CHO cell), Placebo)

Recruiting
  • COVID-19
  • Part1:Recombinant two-component COVID-19 vaccine (CHO cell)
  • +3 more
  • Roxas City, Philippines
    The Health Centrum
Sep 29, 2022

Skin Diseases Trial (Exposed to UV)

Not yet recruiting
  • Skin Diseases
  • Exposed to UV
  • (no location specified)
Mar 10, 2023

Cancer, Solid Tumor, Hematologic Malignancy Trial in Hangzhou (engineered red blood cell WTX212)

Recruiting
  • Cancer
  • +2 more
  • engineered red blood cell WTX212
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People'S Hospital
Jan 21, 2023

Pulmonary Transplantation Trial in Hangzhou (Early Lung Rehabilitation Training, Routine treatment)

Recruiting
  • Pulmonary Transplantation
  • Early Lung Rehabilitation Training
  • Routine treatment
  • Hangzhou, Zhejiang, China
    SAHZhejiangU
Jun 2, 2021

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Kidney Transplant Rejection, Medication Adherence Trial in Aurora (Medication Event Monitoring System (MEMS), Once-Daily

Terminated
  • Kidney Transplant Rejection
  • Medication Adherence
  • Medication Event Monitoring System (MEMS)
  • Once-Daily Tacrolimus extended release
  • Aurora, Colorado
    Children's Hospital Colorado
Nov 30, 2020

Spinal Cord Injury Cervical Trial in Badalona, A Coruña (WJ-MSC (XCEL-UMC-BETA), Placebo)

Active, not recruiting
  • Spinal Cord Injury Cervical
  • WJ-MSC (XCEL-UMC-BETA)
  • Placebo
  • Badalona, Barcelona, Spain
  • +1 more
Jul 5, 2022

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 Trial in United States

Recruiting
  • Metastatic Renal Cell Carcinoma
  • +3 more
  • Avelumab
  • +7 more
  • Danville, Illinois
  • +4 more
Jul 29, 2022

FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at

Recruiting
  • Monkeypox
    • Antwerp, Belgium
      Institute of Tropical Medicine
    May 19, 2023

    Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and

    Not yet recruiting
    • Multiple Sclerosis
    • Progressive Multifocal Leukoencephalopathy
    • 89 Zr-Df-crefmirlimab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    May 13, 2023

    Diabetic Foot Ulcer Associated With Type II Diabetes, Wound Heal Trial in Villa Alemana (InbioDerm + C plus advanced healing,

    Recruiting
    • Diabetic Foot Ulcer Associated With Type II Diabetes Mellitus
    • Wound Heal
    • InbioDerm + C plus advanced healing
    • Advanced healing
    • Villa Alemana, Valparaíso, Chile
      Centro de Salud Familiar de Villa Alemana
    Feb 1, 2022

    Acute Myeloid Leukemia, Lymphoma, Mantle-Cell Trial (PEP07)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Lymphoma, Mantle-Cell
    • (no location specified)
    Dec 22, 2022

    Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)

    Active, not recruiting
    • Renal Cell Cancer
    • +9 more
    • PF-07263689
    • Sasanlimab
    • Duarte, California
    • +5 more
    Nov 8, 2022

    Psoriasis Trial in Cleveland (Ustekinumab)

    Not yet recruiting
    • Psoriasis
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center
    Jul 6, 2022

    Study to Evaluate Effectiveness and Safety of Polatuzumab

    Unknown status
    • Diffuse Large B-Cell Lymphoma (DLBCL)
    • Polatuzumab Vedotin-Piiq
    • Nanjing, Jiangsu, China
      Jiangsu Cancer Hospital
    Nov 10, 2020

    Acute-On-Chronic Liver Failure In Cirrhotic Patients

    Completed
    • Cirrhosis, Liver
      • Sohag, Egypt
        Sohag University
      May 12, 2022

      DREPADOM - Home Care Services and Hospitalizations for Sickle

      Completed
      • Sickle Cell Disease
        • Creteil, France
          Henri Mondor Hospital
        Dec 12, 2022

        Extensive Stage Small Cell Lung Cancer

        Completed
        • Extensive Stage Small Cell Lung Cancer
        • First line EC/EP+Atezolizumab
        • Changsha, Hunan, China
          Hunan Cancer Hospital
        Jan 22, 2022